Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease.

This study has been completed.

Sponsor:

Collaborator:

Information provided by:

Stanford University

ClinicalTrials.gov Identifier:

NCT00240019

First received: October 13, 2005

Last updated: October 16, 2006

Last verified: June 2006

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	April 2006
Estimated Primary Completion Date:	No date given